Executive Director Im Yeong-ae's Shareholding Reduced to 787 from 3,935 Due to Reverse Stock Split, Ownership Ratio Unchanged at 0.01%


  • The number of shares held by Executive Director Im Yeong-ae decreased from 3,935 to 787 due to a reverse stock split, but the ownership ratio remained unchanged at 0.01%.
  • The reverse stock split reduced total outstanding shares from 27,887,050 to 5,577,410 at a 5:1 ratio, having no direct impact on shareholder value.
  • The reduction in individual shareholding is a mechanical adjustment from the stock split, unrelated to investment risk or management changes.
  • [AI Summary]The change in executive shareholding due to the reverse stock split is a routine administrative adjustment with no material effect on shareholder value or ownership percentage, thus neutral.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: KMPHARMACEUTICAL (225430)
  • Submission: Im Yeong-ae
  • Receipt: 06-01-2026